Stratos Wealth Partners, LTD.
Source: SEC Form 13F · as of Mar 2026Stratos Wealth Partners, LTD. holds 19 biotech & pharma companies tracked by BioSniper, totaling $22.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$22.2M
BioSniper AIPage context preserved
Prepared research question
What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| GILDGILEAD SCIENCES, INC. | 84,091 | $11.7M |
| ZVRAZEVRA THERAPEUTICS, INC. | 408,000 | $3.8M |
| PLXProtalix BioTherapeutics, Inc. | 500,000 | $1.1M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 12,884 | $711K |
| INCYIncyte Corp. | 6,895 | $649K |
| SNYSanofi | 12,958 | $624K |
| IONSIONIS PHARMACEUTICALS INC | 7,715 | $579K |
| BBIOBridgeBio Pharma, Inc. | 6,640 | $493K |
| TEVATeva Pharmaceutical Industries Limited | 13,465 | $406K |
| EXELEXELIXIS, INC. | 9,093 | $390K |
| ARQTArcutis Biotherapeutics, Inc. | 15,821 | $373K |
| RXRXRECURSION PHARMACEUTICALS, INC. | 99,894 | $307K |
| REGNREGENERON PHARMACEUTICALS, INC. | 391 | $302K |
| INSMINSMED Inc | 1,502 | $246K |
| HROWHARROW, INC. | 5,898 | $208K |
| OCULOCULAR THERAPEUTIX, INC | 20,000 | $169K |
| GALTGALECTIN THERAPEUTICS INC | 19,888 | $55K |
| CHRSCoherus Oncology, Inc. | 16,131 | $27K |
| SGMOQSANGAMO THERAPEUTICS, INC | 18,040 | $4K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.